AMBER MAYFIELD: Open Payments
NPI 1891860094 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,290 in 108 payments from 15 companies in 2025. Trend: 2023 $2,094 · 2024 $2,271 · 2025 $2,290
Food & beverage: $2,274Education: $16
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $531 |
| UCB, Inc. | 14 | $388 |
| GENZYME CORPORATION | 7 | $200 |
| Lilly USA, LLC | 7 | $173 |
| E.R. Squibb & Sons, L.L.C. | 9 | $158 |
| Janssen Biotech, Inc. | 10 | $151 |
| Novartis Pharmaceuticals Corporation | 7 | $149 |
| Regeneron Healthcare Solutions, Inc. | 8 | $149 |
| Galderma Laboratories, L.P. | 5 | $113 |
| Amgen Inc. | 3 | $65 |
Products named: Bimzelx, SKYRIZI, DUPIXENT, RINVOQ, TALTZ, Sotyktu, TREMFYA, COSENTYX.
Industry payments across GA — which companies pay providers there.
